Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2007;38:1238-1244
Published online before print March 1, 2007, doi: 10.1161/01.STR.0000260095.94175.d0
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
38/4/1238    most recent
01.STR.0000260095.94175.d0v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, R.
Right arrow Articles by Levine, B. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, R.
Right arrow Articles by Levine, B. D.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*PHENYLEPHRINE
Related Collections
Right arrow Autonomic, reflex, and neurohumoral control of circulation
Right arrow Brain Circulation and Metabolism
Right arrow Doppler ultrasound, Transcranial Doppler etc.

(Stroke. 2007;38:1238.)
© 2007 American Heart Association, Inc.


Original Contributions

Autonomic Ganglionic Blockade Does Not Prevent Reduction in Cerebral Blood Flow Velocity During Orthostasis in Humans

Rong Zhang, PhD Benjamin D. Levine, MD

From Institute for Exercise and Environmental Medicine, Presbyterian Hospital of Dallas, Tex; and the University of Texas Southwestern Medical Center at Dallas, Tex.

Correspondence to Rong Zhang, PhD, Institute for Exercise and Environmental Medicine, 7232 Greenville Ave, Dallas, TX 75231. E-mail rongzhang{at}TexasHealth.org

Background and Purpose— The underlying mechanisms for reductions in cerebral blood flow (CBF) during orthostasis are not completely understood. This study tested the hypothesis that sympathetic activation causes cerebral vasoconstriction leading to reductions in CBF during lower body negative pressure (LBNP).

Methods— CBF velocity, arterial pressure, and end-tidal CO2 were measured during LBNP (–30 to –50 mm Hg) in 11 healthy subjects before and after autonomic ganglionic blockade with trimethaphan. Arterial partial pressure of CO2 also was measured in a subgroup of 5 subjects. Mean arterial pressure during LBNP after blockade was maintained by infusion of phenylephrine.

Results— Before blockade, mean arterial pressure did not change during LBNP. However, CBF velocity was reduced in all subjects by 14% (P<0.05). Systolic and pulsatile (systolic–diastolic) CBF velocity were reduced by 18% and 28%, respectively, associated with significant reductions in pulse arterial pressure and end-tidal CO2 (all P<0.05). After blockade, mean arterial pressure during LBNP was well-maintained and even increased slightly with infusion of phenylephrine. However, reductions in mean, systolic, and pulsatile CBF velocity, pulse arterial pressure, and ETCO2 were similar to those before blockade. In contrast to reductions in end-tidal CO2, arterial partial pressure of CO2 did not change during LBNP.

Conclusions— These data, contrary to our hypothesis, demonstrate that sympathetic vasoconstriction is not the primary mechanism underlying reductions in CBF during moderate LBNP. We speculate that diminished pulse arterial pressure or pulsatile blood flow may reduce cerebral vessel wall shear stress and contribute to reductions in CBF during orthostasis through flow mediated regulatory mechanisms.


Key Words: cerebral hemodynamics • orthostasis • sympathetic nervous system • transcranial Doppler